Skip to content

Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer

Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer - Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021878
Enrollment
856
Registered
2016-04-12
Start date
2013-12-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-muscle invasive bladder cancer

Interventions

None listed

Sponsors

Juntendo University, Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In this multicentre retrospective cohort study, we analyzed data from patients with NMIBC who underwent initial TUR-Bt at 4 Juntendo University Hospitals and Teikyo University Hospital between 2000 and 2013 (JT cohort). To achieve adequate pathological staging, the complete resection aimed to include the muscle layer of the bladder wall.

Exclusion criteria

Exclusion criteria: Patients with any of the following were excluded from this analysis: (i) non-Urothelial carcinoma histology, (ii) follow-up periods < 3 months: (iii) history of muscle-invasive or metastatic bladder cancer; (iv) history of carcinoma of the urethra, prostate (ducts or stroma), or upper urinary tract; (v) history of local radiation therapy to the pelvis; (vi) history of every kind of chemotherapy; (vii) history of previous bacillus Calmette-Guerin (BCG) therapy.

Design outcomes

Primary

MeasureTime frame
Recurrence free survival rate

Secondary

MeasureTime frame
Progression disease, and death of bladder cancer

Countries

Japan

Contacts

Public ContactTakeshi Ieda

Juntendo University, Graduate School of Medicine Department of Urology

tieda@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026